Ju Fu Tang Biotech Holdings Co., Ltd (HKG:8217)
Hong Kong · Delayed Price · Currency is HKD 0.2060
-0.0140 (-6.36%)
Jun 1, 2026, 3:01 PM HKT
HKG:8217 Cash Flow Statement
Financials in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Net Income | 20.24 | -5.9 | -17.43 | -9.96 | -20.15 | -13.13 |
Depreciation & Amortization | 0.08 | 0.08 | 0.08 | 0.11 | 0.34 | 2.31 |
Loss (Gain) From Sale of Assets | - | - | - | -0.56 | -0.09 | 11.97 |
Asset Writedown & Restructuring Costs | - | - | - | - | 0.51 | 2.62 |
Loss (Gain) From Sale of Investments | -5.35 | -5.35 | 13.29 | 1.39 | -1.99 | -9.38 |
Stock-Based Compensation | - | - | - | - | 2.57 | 1.6 |
Provision & Write-off of Bad Debts | 3.55 | 3.55 | -1.07 | 4 | 11.58 | 7.11 |
Other Operating Activities | -23.07 | 0.72 | 0.72 | 0.72 | -0.47 | -3.21 |
Change in Accounts Receivable | 1.02 | 1.02 | 8.15 | 32.11 | -0.77 | 50.35 |
Change in Accounts Payable | -1.39 | -1.39 | 0.62 | 5.38 | -8.67 | -16.05 |
Change in Unearned Revenue | - | - | - | -1.88 | 3.4 | - |
Change in Other Net Operating Assets | - | - | -0.7 | 1.88 | -3.4 | - |
Operating Cash Flow | -4.93 | -7.27 | 3.72 | 32.23 | -19.52 | 28.54 |
Operating Cash Flow Growth | - | - | -88.45% | - | - | - |
Sale of Property, Plant & Equipment | - | - | - | 0.8 | 0.09 | 4.37 |
Other Investing Activities | - | - | - | 0.01 | - | 0.02 |
Investing Cash Flow | - | - | - | 0.81 | 0.09 | 4.39 |
Short-Term Debt Issued | - | 5.38 | - | - | - | - |
Long-Term Debt Issued | - | - | - | - | - | 12 |
Total Debt Issued | 5.38 | 5.38 | - | - | - | 12 |
Short-Term Debt Repaid | - | - | -7.77 | -32.93 | -41.01 | -37.92 |
Long-Term Debt Repaid | - | - | - | -0.16 | -0.27 | -0.31 |
Total Debt Repaid | - | - | -7.77 | -33.09 | -41.28 | -38.24 |
Net Debt Issued (Repaid) | 5.38 | 5.38 | -7.77 | -33.09 | -41.28 | -26.24 |
Issuance of Common Stock | - | - | - | - | 54.85 | 5.3 |
Other Financing Activities | - | - | -0.1 | - | -1.52 | -0.25 |
Financing Cash Flow | 5.38 | 5.38 | -7.87 | -33.09 | 12.05 | -21.18 |
Net Cash Flow | 0.45 | -1.89 | -4.15 | -0.05 | -7.37 | 11.75 |
Free Cash Flow | -4.93 | -7.27 | 3.72 | 32.23 | -19.52 | 28.54 |
Free Cash Flow Growth | - | - | -88.45% | - | - | - |
Free Cash Flow Margin | -17.91% | -20.08% | 10.59% | 30.81% | -21.04% | 16.96% |
Free Cash Flow Per Share | -0.02 | -0.02 | 0.01 | 0.11 | -0.10 | 0.33 |
Cash Interest Paid | - | - | 0.1 | - | - | 0.01 |
Levered Free Cash Flow | 4.55 | -3.5 | 4.6 | 33.28 | 2.39 | 34.32 |
Unlevered Free Cash Flow | 5 | -3.05 | 5.05 | 33.73 | 2.85 | 34.49 |
Change in Working Capital | -0.37 | -0.37 | 8.14 | 36.53 | -11.81 | 28.65 |